News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
278,324 Results
Type
Article (14477)
Company Profile (101)
Press Release (263745)
Multimedia
Podcasts (71)
Webinars (14)
Section
Business (88404)
Career Advice (468)
Deals (15455)
Drug Delivery (83)
Drug Development (36802)
Employer Resources (50)
FDA (6416)
Job Trends (6247)
News (150978)
Policy (14149)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (452)
Accelerated approval (25)
ADA (10)
Adcomms (9)
Allergies (98)
Alliances (23326)
ALS (74)
Alzheimer's disease (523)
Antibody-drug conjugate (ADC) (169)
Approvals (6734)
Artificial intelligence (277)
ASCO (115)
Autoimmune disease (79)
Automation (22)
Bankruptcy (152)
Best Places to Work (4370)
BIO (20)
BIOSECURE Act (9)
Biosimilars (152)
Biotechnology (39)
Bladder cancer (51)
Brain cancer (41)
Breast cancer (211)
Cancer (1749)
Cardiovascular disease (202)
Career advice (422)
Career pathing (14)
CAR-T (66)
CDC (7)
Cell therapy (200)
Cervical cancer (20)
Clinical research (32655)
Collaboration (959)
Commercialization (1)
Company closure (1)
Compensation (402)
Complete response letters (47)
COVID-19 (786)
CRISPR (54)
C-suite (647)
Cystic fibrosis (62)
Data (2554)
Decentralized trials (1)
Denatured (19)
Depression (60)
Dermatology (16)
Diabetes (167)
Diagnostics (1459)
Digital health (16)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (168)
Drug pricing (122)
Drug shortages (15)
Duchenne muscular dystrophy (100)
Earnings (34249)
Editorial (24)
Employer branding (4)
Employer resources (46)
Events (39980)
Executive appointments (614)
FDA (7834)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (554)
Gene editing (86)
Generative AI (28)
Gene therapy (203)
GLP-1 (495)
Government (1432)
Grass and pollen (4)
Guidances (173)
Healthcare (3639)
Hematology (66)
HIV (17)
Huntington's disease (12)
IgA nephropathy (52)
Immunology and inflammation (85)
Immuno-oncology (31)
Indications (99)
Infectious disease (885)
Inflammatory bowel disease (88)
Inflation Reduction Act (7)
Influenza (29)
Intellectual property (138)
Interviews (60)
IPO (5936)
IRA (33)
Job creations (2060)
Job search strategy (375)
JPM (29)
Kidney cancer (12)
Labor market (38)
Layoffs (211)
Leadership (10)
Legal (3450)
Liver cancer (26)
Longevity (10)
Lung cancer (240)
Lymphoma (161)
Machine learning (16)
Management (17)
Manufacturing (572)
Marketing (1)
MASH (91)
Medical affairs (1)
Medical device (1313)
Medtech (1330)
Mergers & acquisitions (10043)
Metabolic disorders (570)
mRNA (64)
Multiple sclerosis (60)
NASH (15)
Neurodegenerative disease (112)
Neuropsychiatric disorders (48)
Neuroscience (1064)
Neurotech (1)
NextGen: Class of 2026 (1589)
Non-profit (608)
Now hiring (24)
Obesity (293)
Opinion (151)
Ovarian cancer (65)
Pain (136)
Pancreatic cancer (72)
Parkinson's disease (110)
Partnered (12)
Patents (280)
Patient recruitment (185)
Peanut (15)
People (30255)
Pharmaceutical (60)
Pharmacy benefit managers (19)
Phase 1 (8454)
Phase 2 (13794)
Phase 3 (12461)
Pipeline (3545)
Policy (150)
Postmarket research (1403)
Preclinical (3412)
Press Release (25)
Prostate cancer (114)
Psychedelics (22)
Radiopharmaceuticals (160)
Rare diseases (475)
Real estate (2669)
Recruiting (19)
Regulatory (11429)
Reports (16)
Research institute (582)
Resumes & cover letters (56)
Rett syndrome (11)
RNA editing (9)
RSV (25)
Schizophrenia (87)
Series A (115)
Series B (66)
Service/supplier (2)
Sickle cell disease (56)
Special edition (11)
Spinal muscular atrophy (85)
Sponsored (11)
Startups (1652)
State (2)
Stomach cancer (6)
Supply chain (64)
Tariffs (71)
The Weekly (50)
Vaccines (273)
Venture capital (40)
Weight loss (172)
Women's health (50)
Worklife (4)
Date
Today (29)
Last 7 days (148)
Last 30 days (874)
Last 365 days (10328)
2026 (5357)
2025 (10718)
2024 (12507)
2023 (14258)
2022 (19563)
2021 (20086)
2020 (19065)
2019 (14896)
2018 (11723)
2017 (13896)
2016 (13131)
2015 (15474)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (323)
Alabama (20)
Alaska (1)
Arizona (88)
Arkansas (4)
Asia (21283)
Australia (2744)
California (3954)
Canada (1800)
China (757)
Colorado (175)
Connecticut (157)
Delaware (170)
Europe (41680)
Florida (753)
Georgia (76)
Hawaii (1)
Idaho (11)
Illinois (459)
India (66)
Indiana (312)
Iowa (2)
Japan (356)
Kansas (84)
Kentucky (21)
Louisiana (7)
Maine (2)
Maryland (502)
Massachusetts (3202)
Michigan (55)
Minnesota (209)
Mississippi (1)
Missouri (39)
Montana (9)
Nebraska (8)
Nevada (19)
New Hampshire (9)
New Jersey (1783)
New Mexico (7)
New York (1136)
North Carolina (744)
North Dakota (2)
Northern California (1869)
Ohio (94)
Oklahoma (5)
Oregon (18)
Pennsylvania (861)
Puerto Rico (18)
Rhode Island (18)
South America (508)
South Carolina (11)
Southern California (1743)
Tennessee (68)
Texas (565)
United States (15724)
Utah (66)
Vermont (1)
Virginia (211)
Washington D.C. (42)
Washington State (290)
West Virginia (1)
Wisconsin (51)
Wyoming (1)
278,324 Results for "beyondspring pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting
May 18, 2026
·
2 min read
Press Releases
BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value
June 4, 2026
·
15 min read
Press Releases
BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026
·
9 min read
Press Releases
BeyondSpring Reports 2025 Year-End Financial Results
March 25, 2026
·
12 min read
Press Releases
BeyondSpring Files 2025 Annual Report on Form 10-K
March 26, 2026
·
2 min read
Press Releases
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
April 22, 2026
·
7 min read
Press Releases
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026
March 30, 2026
·
1 min read
Press Releases
BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference
February 9, 2026
·
1 min read
Press Releases
BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026
June 2, 2026
·
5 min read
Press Releases
BeyondSpring Reports Third‑Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
·
12 min read
1 of 27,833
Next
